Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM5A | P29375 | 4/20 | 0.65 |
| ▸ | PHF8 | Q9UPP1 | 4/20 | 0.65 |
| ▸ | KDM2A | Q9Y2K7 | 4/20 | 0.65 |
| ▸ | KDM4C | Q9H3R0 | 3/20 | 0.65 |
| ▸ | KDM7A | Q6ZMT4 | 1/20 | 0.65 |
| ▸ | LMNA | P02545 | 3/20 | 0.57 |
| ▸ | TSHR | P16473 | 3/20 | 0.57 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.57 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.57 |
| ▸ | KDM4A | O75164 | 1/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | ACHE | P22303 | 1/20 | 0.50 |
| ▸ | APEX1 | P27695 | 1/20 | 0.50 |
| ▸ | RECQL | P46063 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31454264 | 1.00 | KDM5A (0.65) | KDM5APHF8KDM2AKDM4CKDM7A | |
| SCHEMBL11848931 | 1.00 | KDM5A (0.65) | KDM5APHF8KDM2AKDM4CKDM7A | |
| SCHEMBL1456488 | 1.00 | KDM5A (0.65) | KDM5APHF8KDM2AKDM4CKDM7A | |
| SCHEMBL1457469 | 1.00 | KDM5A (0.65) | KDM5APHF8KDM2AKDM4CKDM7A | |
| SCHEMBL4449247 | 1.00 | KDM5A (0.65) | KDM5APHF8KDM2AKDM4CKDM7A | |
| SCHEMBL11851432 | 1.00 | KDM5A (0.65) | KDM5APHF8KDM2AKDM4CKDM7A | |
| SCHEMBL16046794 | 1.00 | KDM5A (0.65) | KDM5APHF8KDM2AKDM4CKDM7A | |
| SCHEMBL11849540 | 1.00 | KDM5A (0.65) | KDM5APHF8KDM2AKDM4CKDM7A | |
| SCHEMBL4978263 | 1.00 | KDM5A (0.65) | KDM5APHF8KDM2AKDM4CKDM7A | |
| SCHEMBL28448757 | 1.00 | KDM5A (0.65) | KDM5APHF8KDM2AKDM4CKDM7A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4728019-A1 | A MICROWAVE CARBONIZATION ASSEMBLY AND METHOD FOR EXTRACTING COMPONENTS FROM RUBBER | Sable Rubber IP Pty Limited (AU) | 2026-04-22 | — | — | EP | disclosed |
| US-20260027078-A1 | Cyclopropane Fatty Acid Modulators Of Peroxisome Proliferator-Activated Receptors | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2026-01-29 | — | — | US | disclosed |
| EP-4561979-A2 | CYCLOPROPANE FATTY ACID MODULATORS OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS | The Regents of the University of California (US) | 2025-06-04 | — | — | EP | disclosed |
| WO-2024257019-A1 | A MICROWAVE CARBONIZATION ASSEMBLY AND METHOD FOR EXTRACTING COMPONENTS FROM RUBBER | Molectra Rubber IP Pty Ltd (AU) | 2024-12-19 | — | — | WO | disclosed |
| US-20240084343-A1 | METHODS OF USING NATURAL AND ENGINEERED ORGANISMS TO PRODUCE SMALL MOLECULES FOR INDUSTRIAL APPLICATION | KIVERDI INC (US) | 2024-03-14 | — | — | US | disclosed |
| WO-2024026460-A2 | CYCLOPROPANE FATTY ACID MODULATORS OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-02-01 | — | — | WO | disclosed |
| US-20210115481-A1 | Methods of Using Natural and Engineered Organisms to Produce Small Molecules for Industrial Application | KIVERDI INC (US) | 2021-04-22 | — | — | US | disclosed |
| US-20170159087-A1 | Methods of Using Natural and Engineered Organisms to Produce Small Molecules for Industrial Application | KIVERDI, INC. (US) | 2017-06-08 | — | — | US | disclosed |
| US-9556462-B2 | Methods of using natural and engineered organisms to produce small molecules for industrial application | KIVERDI, INC. (US) | 2017-01-31 | — | — | US | disclosed |
| EP-2971023-A2 | METHODS OF USING NATURAL AND ENGINEERED ORGANISMS TO PRODUCE SMALL MOLECULES FOR INDUSTRIAL APPLICATION | Kiverdi, Inc. (US) | 2016-01-20 | — | — | EP | disclosed |
| US-20140273112-A1 | METHODS OF USING NATURAL AND ENGINEERED ORGANISMS TO PRODUCE SMALL MOLECULES FOR INDUSTRIAL APPLICATION | KIVERDI, INC. (US) | 2014-09-18 | — | — | US | disclosed |
| WO-2014145194-A2 | METHODS OF USING NATURAL AND ENGINEERED ORGANISMS TO PRODUCE SMALL MOLECULES FOR INDUSTRIAL APPLICATION | KIVERDI, INC. (US) | 2014-09-18 | — | — | WO | disclosed |
| US-8802405-B2 | Ethanologenic Clostridium species, Clostridium coskatii | COSKATA, INC. (US) | 2014-08-12 | — | — | US | disclosed |
| EP-2547759-A2 | A NOVEL ETHANOLOGENIC CLOSTRIDIUM SPECIES, CLOSTRIDIUM COSKATII | Coskata, Inc. (US) | 2013-01-23 | — | — | EP | disclosed |
| US-20120156747-A1 | Novel Ethanologenic Clostridium species, Clostridium coskatii | COSKATA, INC. (US) | 2012-06-21 | — | — | US | disclosed |
| US-8143037-B2 | Ethanologenic Clostridium species, Clostridium coskatii | COSKATA, INC. (US) | 2012-03-27 | — | — | US | disclosed |
| US-20110229947-A1 | Novel Ethanologenic Clostridium species, Clostridium coskatii | COSKATA, INC. (US) | 2011-09-22 | — | — | US | disclosed |
| WO-2011116124-A2 | A NOVEL ETHANOLOGENIC CLOSTRIDIUM SPECIES, CLOSTRIDIUM COSKATII | COSKATA, INC. (US) | 2011-09-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260027078-A1 | Cyclopropane Fatty Acid Modulators Of Peroxisome Proliferator-Activated Receptors | FABP2, FABP1, FABP4 | KDM5A 4206/4885PHF8 1206/4885KDM2A 2737/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.